Cargando…
Stage IV non-small cell lung cancer among young individuals: Incidence, presentations, and survival outcomes of conventional therapies
BACKGROUND: There is a paucity of data published on the clinicopathological features and prognosis of stage IV non-small cell lung cancer (NSCLC) patients aged ≤45 years. Herein, we evaluated a large clinical series in an effort to provide a clearer picture of this population. METHODS: The least abs...
Autores principales: | Cai, Jing-Sheng, Qiu, Man-Tang, Yang, Fan, Wang, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691661/ https://www.ncbi.nlm.nih.gov/pubmed/36439488 http://dx.doi.org/10.3389/fonc.2022.894780 |
Ejemplares similares
-
Survival of Black and White Patients With Stage IV Small Cell Lung Cancer
por: Shi, Huashan, et al.
Publicado: (2021) -
Aggressive Local Treatment Improves Survival in Stage IV Breast Cancer With Synchronous Metastasis
por: Lian, Chen-Lu, et al.
Publicado: (2020) -
Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma
por: Li, Zefeng, et al.
Publicado: (2022) -
Clinical and Biological Interpretation of Survival Curves of Cancer Patients, Exemplified With Stage IV Non-Small Cell Lung Cancers With Long Follow-up
por: Baak, Jan P. A., et al.
Publicado: (2022) -
Impact of Postoperative Radiotherapy on Survival of Patients With de novo Stage IV Breast Cancer: A Population-Based Study From the SEER Database
por: Zhang, Jie, et al.
Publicado: (2021)